Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-20

Clinical Trial Update: Investigating the Effects of Probiotic Yoghurt on Reducing the Levels of Aflatoxin B1 Toxin Among the School Children in Eastern Kenya [NA]

View source ↗

Summary

A clinical trial is evaluating whether probiotic yoghurt can reduce aflatoxin B1 levels in schoolchildren in Eastern Kenya.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic Yoghurt

Snippet

Sponsor: Technical University of Kenya | Conditions: Aflatoxicosis | NA | Status: UNKNOWN